SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$417,000
-41.1%
23,871
-19.2%
0.01%
-38.5%
Q2 2021$708,000
-32.1%
29,557
-27.1%
0.01%
-27.8%
Q1 2021$1,042,000
+89.5%
40,567
+40.0%
0.02%
+80.0%
Q4 2020$550,00028,9670.01%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders